|| Checking for direct PDF access through Ovid
(Can J Anaesth. 2016;63(9):1075–1097)Failure of timely diagnosis and treatment of hypertensive disorders of pregnancy (HDP) contributes significantly to maternal and neonatal morbidities such as neurological complications, pulmonary edema, postpartum hemorrhage; neonatal respiratory and neurological complications and stillbirth. HDP affects 3% to 8% of all pregnancies and special attention to its diagnosis and treatment is needed to curb maternal and neonatal mortality and morbidity. Hypertension without proteinuria, as well as preexisting hypertension, has been occurring more frequently, specifically in older pregnant women. In Canada, the maternal and infant mortality rates have been controlled with improved medical care to women. The Society of Obstetricians and Gynaecologists of Canada (SOGC) guidelines on the classification, clinical features, laboratory investigations, diagnosis, and care of HDP, which are outlined in this article and emphasize a multidepartmental team including anesthesiologists, enhance the quality of medical care. The guidelines were published in 2008 and revised in 2014.